After years of unrelenting demand for FDA-regulated, controlled-temperature storage and distribution of pharmaceuticals and medical devices, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, announced the company will open another multi-client facility near Indianapolis in January 2022, creating 50-100 jobs and planting a larger flag for LSL in the U.S. distribution “hub” city.
The new 440,000-square-foot Clayton, IN facility is the third LSL multi-client, controlled-temperature/cold storage facility in the Indianapolis area.
“All of the hard work we’ve been doing for the past 15 years to perfect our operations, manage quality and listen closely to our clients’ needs has led us to this moment,” said Life Science Logistics CEO Richard Beeny. “We’ve watched the consolidation of 3rd-party logistics providers across our industry and are proud to be the last and leading independent standing in a sea of middle-market demand. Our clients are saying ‘please build it, we need more’ – and we want to be their ‘Easy’ button.”
The fast-growing company of more than 600 employees, which currently has 12 controlled-temperature (20-25 degrees Celsius) and cold chain (2-8 degrees Celsius) storage and distribution locations across nine states – from Dallas to New York to Seattle – aims to continue its coast-to-coast growth.
He points to the speed with which new FDA-approved pharmaceutical and medical devices are being brought to market, as well demand for storage and distribution services driven by COVID-19 and injectable drugs with “live” particulates requiring extreme freezes to preserve vaccine integrity, as the primary drivers of growth.
When combined with the existing 526,299 square feet at the Brownsburg, IN facility and the 189,458 square feet at the Whitestown, IN facility, the new, 440,000-square-foot Clayton facility brings LSL’s total combined Indianapolis footprint of mixed-use, FDA-regulated storage and distribution space to more than 1 million square feet.
